Grant opportunityArchived
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
RFA-NS-24-013 · NIH
Grant details are part of the paid plan
Award amounts, eligibility, deadlines, and the application link — plus grant alerts the moment new funding posts.
Create an account →